Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
74 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Rayvax Société d'Investissements from Elsene, company number BE0421798659, closed financial year 2025 with a result of € 88,831 after tax. Compared with financial year 2024, the result moved from € 130,303 to € 88,831. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.
€ 2.9 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 88,831
▼ 32% vs 2024
Profit after tax over the fiscal year.
€ 61,423
▼ 93% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.4 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 4,704,919 | € -620 | - | - | |
| Profit after taxes | € -161,467 | € 3,010,436 | € 130,303 | € 88,831 | ▼ 32% |
| Equity | € 19,374,611 | € 4,685,047 | € 2,811,592 | € 2,900,423 | ▲ 3% |
| Total debts | € 10,389,935 | € 17,700,000 | € 2,019,591 | € 7,000 | ▼ € 2 million |
| Cash | € 16,182,565 | € 13,591,481 | € 934,438 | € 61,423 | ▼ 93% |
| Retained profit | € 17,910,982 | € 3,221,418 | € 1,347,962 | € 1,436,794 | ▲ 7% |
| Dividend | € 0 | € 17,700,000 | € 2,003,758 | € 0 | ▼ 100% |
| Balance sheet total | € 29,764,546 | € 22,385,047 | € 4,831,183 | € 2,907,423 | ▼ 40% |
Key figures of Rayvax Société d'Investissements, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Rayvax Société d'Investissements?
What happened at Rayvax Société d'Investissements in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Arnoud DE PRET ROOSE DE CALESBERG stepped down as director. NBB
- Elinor DE PRET ROOSE DE CALSEBERG stepped down as director. NBB
- Valentine DE PRET ROOSE DE CALESBERG stepped down as director. NBB
- Lavinia DE PRET ROOSE DE CALESBERG stepped down as director. NBB
- Gérard LAMARCHE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 88,831 (▼ 32% vs 2024). Source: NBB ↗
- Arnoud DE PRET ROOSE DE CALESBERG became a director. NBB
- Elinor DE PRET ROOSE DE CALSEBERG became a director. NBB
In short
From € 161,467 loss in 2022 to € 88,831 profit in 2025.
Paid € 1,972 in corporate taxes since 2022.
Best year ever: 2023, with € 3 million profit.
Paid out € 19.7 million in dividends to the owners in total.
A new publication or filing at Rayvax Société d'Investissements? We notify you, reason included.
Follow Rayvax Société d'InvestissementsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MULTIFIN, DURNABLE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Rayvax Société d'InvestissementsThe shares are held by MULTIFIN (100%) and DURNABLE (12.8%).
Directors
According to the 2025 annual accounts
Arnoud DE PRET ROOSE DE CALESBERG
Director
Also active at: MULTIFIN, ERCOLAND, DURNABLE, FOUR SEVENTY ONE, Blue Mountain Owl, ROUGE, NOIRE, Bleue +1 more
since 2023 · until 2029
Elinor DE PRET ROOSE DE CALSEBERG
Director
since 2023 · until 2029
Valentine DE PRET ROOSE DE CALESBERG
Director
since 2023 · until 2029
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Gachardstraat 88 box 14
1050 Elsene
Sterrenkundelaan 11
1210 Sint-Joost-ten-Node
Active since 9 September 1981
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 74 companies are registered at this address.
All companies at this address →Casteau Homes
Prevent, Instituut voor Preventie en Welzijn op het Werk
Association des Chefs de Service de Securité et d'Hygiène de Belgique - Vereniging van Diensthoofden voor veiligheid en Hygiëne van België
Centre de Prévention du Suicide
€ 103,939 revenue · 2025
EFMD
€ 6.3 million revenue · 2025
+69 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0421.798.659
- VAT number
- BE 0421.798.659
- Registered office
- Gachardstraat 88 bus 14, 1050 Elsene
- Names & denominations
- Rayvax Société d'Investissements · Rayvax
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 June 1981
- Peppol
- Active · Active since 16 Jan 2026